Conversion of mouse mammary tumor virus to a lymphomagenic virus

Journal of Virology

Volumn 79, Issue 19, 2005, Pages 12592-12596

  Bhadra, Sanchita ^a   Lozano, Mary M ^a   Dudley, Jaquelin P ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER MODEL; CONTROLLED STUDY; ENHANCER REGION; GENE DELETION; GENE INSERTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LEUKEMIA VIRUS; LONG TERMINAL REPEAT; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; REGULATORY DNA SEQUENCE; T LYMPHOCYTE; THYMUS LYMPHOMA; TRANSCRIPTION REGULATION; VIRUS CARCINOGENESIS; VIRUS MUTATION;

ANIMALS; CELL LINE; ENHANCER ELEMENTS (GENETICS); GENES, REGULATOR; HUMANS; JURKAT CELLS; LYMPHOMA, T-CELL; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED BALB C; PROVIRUSES; RETROVIRIDAE INFECTIONS; T-LYMPHOCYTES; TERMINAL REPEAT SEQUENCES; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR VIRUS INFECTIONS;

LEUKEMOGENIC VIRUS; MOUSE MAMMARY TUMOR VIRUS;

EID: 25144494619     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.19.12592-12596.2005     Document Type: Article

References (26)

1. Ball, J. K., and G. A. Dekaban. 1987. Characterization of early molecular biological events associated with thymic lymphoma induction following infection with a thymotropic type-B retrovirus. Virology 161:357-365.
2. 3 region of the long terminal repeat of an infectious thymotropic type B retrovirus. J. Virol. 62:2985-2993.
3. Bramblett, D., C.-L. L. Hsu, M. Lozano, K. Earnest, C. Fabritius, and J. Dudley. 1995. A redundant nuclear protein binding site contributes to negative regulation of the mouse mammary tumor virus long terminal repeat. J. Virol. 69:7868-7876.
4. Brasset, E., and C. Vaury. 2005. Insulators are fundamental components of the eukaryotic genomes. Heredity 94:571-576.
5. Broussard, D. R., M. M. Lozano, and J. P. Dudley. 2004. Rorγ (Rorc) is a common integration site in type B leukemogenic virus-induced T-cell lymphomas. J. Virol. 78:4943-4946.
6. Broussard, D. R., J. A. Mertz, M. Lozano, and J. P. Dudley. 2002. Selection for c-myc integration sites in polyclonal T-cell lymphomas. J. Virol. 76:2087-2099.
7. Dudley, J., and R. Risser. 1984. Amplification and novel locations of endogenous mouse mammary tumor virus genomes in mouse T-cell lymphomas. J. Virol. 49:92-101.
8. Dudley, J. P. 1999. Mouse mammary tumor virus, p. 965-972. In R. G. Webster and A. Granoff (ed.), Encyclopedia of virology. Academic Press Ltd., London, United Kingdom.
9. Hsu, C.-L. L., C. Fabritius, and J. Dudley. 1988. Mouse mammary tumor virus proviruses in T-cell lymphomas lack a negative regulatory element in the long terminal repeat. J. Virol. 62:4644-4652.
10. Lee, J. W., P. G. Moffitt, K. L. Morley, and D. O. Peterson. 1991. Multipartite structure of a negative regulatory element associated with a steroid hormone-inducible promoter. J. Biol. Chem. 266:24101-24108.
11. Liu, J., D. Bramblett, Q. Zhu, M. Lozano, R. Kobayashi, S. R. Ross, and J. P. Dudley. 1997. The matrix attachment region-binding protein SATB1 participates in negative regulation of tissue-specific gene expression. Mol. Cell. Biol. 17:5275-5287.
12. Mertz, J. A., F. Mustafa, S. Meyers, and J. P. Dudley. 2001. Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1. J. Virol. 75:2174-2184.
13. Michalides, R., E. Wagenaar, and P. Weijers. 1985. Rearrangements in the long terminal repeat of extra mouse mammary tumor proviruses in T-cell leukemias of mouse strain GR result in a novel enhancer-like structure. Mol. Cell. Biol. 5:823-830.
14. Mustafa, F., S. Bhadra, D. Johnston, M. Lozano, and J. P. Dudley. 2003. The type B leukemogenic virus truncated superantigen is dispensable for T-cell lymphomagenesis. J. Virol. 77:3866-3870.
15. Mustafa, F., M. Lozano, and J. P. Dudley. 2000. C3H mouse mammary tumor virus superantigen function requires a splice donor site in the envelope gene. J. Virol. 74:9431-9440.
16. Papiernik, M., A. C. Wache, C. Pontoux, and B. Nabarra. 1997. Massive mammary gland infection and pregnancy-dependent mammary tumor development in mice infected neonatally with mouse mammary tumor virus (SW) but not in mice infected as adults, despite a dramatic local response. Eur. J. Immunol. 27:2145-2151.
17. Purdy, A., L. Case, M. Duvall, M. Overstrom-Coleman, N. Monnier, A. Chervonsky, and T. Golovkina. 2003. Unique resistance of I/LnJ mice to a retrovirus is due to sustained interferon gamma-dependent production of virus-neutralizing antibodies. J. Exp. Med. 197:233-243.
18. Rajan, L., D. Broussard, M. Lozano, C. G. Lee, C. A. Kozak, and J. P. Dudley. 2000. The c-myc locus is a common integration site in type B retrovirus-induced T-cell lymphomas. J. Virol. 74:2466-2471.
19. Ross, S. R., C.-L. L. Hsu, Y. Choi, E. Mok, and J. P. Dudley. 1990. Negative regulation in correct tissue-specific expression of mouse mammary tumor virus in transgenic mice. Mol. Cell. Biol. 10:5822-5829.
20. Shackleford, G. M., and H. E. Varmus. 1988. Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. Proc. Natl. Acad. Sci. USA 85:9655-9659.
21. Theunissen, H. J. M., M. Paardekooper, L. J. Maduro, R. J. A. M. Michalides, and R. Nusse. 1989. Phorbol ester-inducible T-cell-specific expression of variant mouse mammary tumor virus long terminal repeats. J. Virol. 63:3466-3471.
22. Wrona, T. J., M. Lozano, A. A. Binhazim, and J. P. Dudley. 1998. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen. J. Virol. 72:4746-4755.
23. Yanagawa, S.-I., K. Kakimi, H. Tanaka, A. Murakami, Y. Nakagawa, Y. Kubo, Y. Yamada, H. Hiai, K. Kuribayashi, T. Masuda, and A. Ishimoto. 1993. Mouse mammary tumor virus with rearranged long terminal repeats causes murine lymphomas. J. Virol. 67:112-118.
24. Yazdanbakhsh, K., C. G. Park, G. M. Winslow, and Y. Choi. 1993. Direct evidence for the role of COOH terminus of mouse mammary tumor virus superantigen in determining T cell receptor Vβ specificity. J. Exp. Med. 178:737-741.
25. Zhu, Q., K. Gregg, M. Lozano, J. Liu, and J. P. Dudley. 2000. CDP is a repressor of mouse mammary tumor virus expression in the mammary gland. J. Virol. 74:6348-6357.
26. Zhu, Q., U. Maitra, D. Johnston, M. Lozano, and J. P. Dudley. 2004. The homeodomain protein CDP regulates mammary-specific gene transcription and tumorigenesis. Mol. Cell. Biol. 24:4810-4823.